STACKED PANCAKE & BREAKFAST HOUSE LAUNCHES FIRST-EVER NATIONAL "STACKED DAY" WITH 50% OFF THE ENTIRE MENU*, JUNE 26
One of Canada's fastest-growing restaurant chains is saying thank you to guests nationwide with a one-day, coast-to-coast half-price celebration across 125 locations and counting.
BARRIE, ON, June 17, 2025 /CNW/ - Stacked Pancake & Breakfast House will celebrate its inaugural National Stacked Day on Thursday, June 26, 2025, by taking 50% off every menu item - from signature pancake stacks and mouth-watering french toast to savoury hashes, benedicts and burgers - at all open Stacked restaurants across Canada.
"Over the past decade, Canadians have welcomed Stacked into their morning routines and lunch breaks," said Manish Mehra, Director at Stacked Franchising Ltd. "Now that we've grown to more than 125 locations nationwide, National Stacked Day lets us say 'thank you' in the biggest way we know - half-price favourites for everyone."
Stacked is quickly earning recognition as one of the country's fastest-growing breakfast chains. Expansion continues through 2025 with new openings planned in Ontario, Vancouver and Nova Scotia, bringing the brand's family-style hospitality to even more Canadian communities.
Founded in Ontario in 2014, Stacked Pancake & Breakfast House is a Canadian-owned and operated family favourite for all things breakfast and lunch. Franchisees are dedicated to quality food and genuine service at an approachable price point. Stacked specializes in fresh takes and creative twists on some of your classic breakfast and lunch items. From locally sourced produce and house-made batters to crave-worthy lunch specials, Stacked has become a go-to destination for guests who believe brunch is more than a meal - it's a moment worth savouring.
The one-day promotion takes place on Thursday, June 26, 2025, when every food and beverage item will be 50%* at all Stacked Pancake & Breakfast House locations nationwide. Each of the 100+ locations will honour the discount during its regular operating hours, with the offer available for dine-in and take-out only (third-party delivery is excluded). Guests are encouraged to join their local store's online waitlist early, with location-specific hours and details found at stackedpancakehouse.ca.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
32 minutes ago
- Cision Canada
Canada Life and ClearEstate Announce Strategic Agreement That Will Help Expand Access to Estate Planning Solutions for Canadians Français
WINNIPEG, MB , June 25, 2025 /CNW/ - Today, Canada Life and ClearEstate, a trusted provider of modern estate planning and settlement solutions, are announcing a strategic agreement that will help make these ClearEstate services more accessible to millions of Canadians. Canada Life has also made an equity investment in ClearEstate, reinforcing its commitment to supporting innovative solutions that simplify estate planning for Canadians. Through this strategic agreement, Canada Life and certain of its subsidiaries will be able to refer certain of their clients, plan members, and employees to ClearEstate for their services. "For generations, Canada Life has worked with financial advisors in Canada to provide industry-leading wealth and financial services to Canadians," said Blaine Shewchuk, EVP Individual Wealth, Canada Life. "By working with ClearEstate—an innovator in delivering scalable, user-friendly digital estate planning and settlement services, we're helping to make it easier for Canadians to access ClearEstate's important services through their financial advisors and workplace benefits." "Canada Life is one of the most trusted names in the financial services industry. This strategic relationship with Canada Life will help allow ClearEstate to provide a valuable service and help even more people than ever before," said Davide Pisanu, CEO of ClearEstate. "It represents a unified commitment to help reshape the way Canadians approach estate planning—making it simple, transparent, and an integral part of their overall financial well-being." As the number of older Canadians continues to rise, ClearEstate and Canada Life are joining forces on a shared vision to help ensure more families have access to the tools and support they need to protect their legacies and reduce the burden on loved ones. ClearEstate is dedicated to solving a long-standing problem: too many Canadians lack proper estate planning services. With an intuitive digital platform, human guidance, and a comprehensive range of services—from will creation and power of attorney documents to professional executorship—ClearEstate empowers users with clarity and confidence. "This agreement validates what we've long believed: that estate planning should be accessible, proactive, and part of every Canadian's financial journey," added Pisanu. "Together, we're helping to create a future where every family can face life's biggest transitions with support and clarity." About ClearEstate ClearEstate's mission is to provide compassionate guidance in life's most important moments. Whether preparing for the future or settling a loved one's estate, Canadians can trust its intuitive web-based solution for a transparent and efficient approach to estate planning, settlement, and executor services. Founded in 2020 and backed by notable investors including Diagram Ventures, OMERS Ventures, and NAventures, ClearEstate has already supported thousands of families across North America. About Canada Life Founded in 1847, Canada Life is a trusted leader in financial and insurance services, committed to helping Canadians achieve their financial goals and protect their families. Through innovative and personalized solutions, Canada Life supports individuals and businesses in building secure financial futures.
Cision Canada
32 minutes ago
- Cision Canada
New report says Canada faces a health security emergency -- and the fix could unlock economic growth
OTTAWA, ON, June 25, 2025 /CNW/ - A new report from the Public Policy Forum (PPF) is calling on the federal government to recognize that Canada faces a national health security emergency and must address escalating threats to the country's health and economic security. With geopolitical instability and declining U.S. leadership in global health, the report warns that Canada must act quickly to modernize how it regulates and approves medicines, as well as build resilience in its life sciences sector. Supply chain disruptions resulting from U.S. trade policy, the erosion of public trust in science and an underinvestment in domestic businesses have all exposed serious vulnerabilities, which, if left unchecked, pose direct threats to the health of Canadians. Titled Canada's Code Red: An urgent playbook to build an economy-boosting life sciences sector, the report highlights the value of Canada's life sciences sector as an investment that will yield health and economic returns. It argues that the threat of an emergency demands a new sense of urgency, with innovative solutions that include: streamlining regulatory processes, enabling more flexible and rapid decision-making and removing bureaucratic bottlenecks that delay life sciences investment and product approvals. Recognition of a national health security emergency would also send a powerful signal to international investors, provincial partners and industry leaders that Canada is committed to becoming a global hub for health innovation and commercialization. The report marks the launch of PPF's new Healthy Canadians, Competitive Canada (HCCC) research program. Under the umbrella of PPF's Mission Canada initiative, the HCCC program will document links between a vibrant life sciences sector and the country's overall economic and social success. "Canada must prioritize resilience, innovation, and self-reliance," the report notes. "The newly elected federal government has an unparalleled opportunity to redefine Canada's life sciences landscape by embracing urgency, dismantling bureaucratic barriers and fostering a culture of innovation." With the right approach, the report says that: "…. Canada can transform its life sciences sector into a cornerstone of national strength — one that protects its citizens' health while contributing significantly to economic prosperity, ensuring healthy Canadians within a competitive Canada." To enable this, the report recommends a series of 'plays': Recognize that Canada faces a national health security emergency, and that meaningful change within regulatory bodies and among government decision-makers must quickly boost the life sciences sector; Fast-track the rollout of Health Emergency Readiness Canada (HERC) to coordinate pandemic preparedness and biomanufacturing capacity; Create a Canadian life sciences performance scorecard to track progress in R&D, talent, infrastructure and investment; Recruit top global talent through a coordinated national life sciences workforce strategy — in particular, fast-tracked immigration and academic placement for U.S. researchers; Adopt a 'made in Canada' strategy to prioritize domestic innovation and reduce reliance on foreign supply chains; and Unlock Canadian health data as a national asset for research and commercialization. "This report is a call to action for policymakers in Canada to respond with determination in supporting Canada's life sciences sector," said Inez Jabalpurwala, President and CEO of the Public Policy Forum. "The vital importance of the sector to Canadians' overall health, as well to the economy as a whole, has long been clear — it must now be addressed with pandemic-level urgency." Written by journalist Christopher Waddell, the report was informed in part by the insights generated by PPF's Life Sciences Forum Leadership Table, co-chaired by Mark Lievonen, principal of JML Advisory Services and former co-chair of Canada's COVID-19 Vaccine Task Force, and Dr. Ilse Treurnicht, managing partner at TwinRiver Capital. "The good news is that with the right policy decisions and decisive action we can turbocharge growth of the life science sector," Ms. Jabalpurwala said, "ensuring our businesses are protecting the health of Canadians, as well as boosting economic growth."
Cision Canada
32 minutes ago
- Cision Canada
LTS and Nualtis Announce Strategic Cooperation to Expand Global Manufacturing Capabilities, Accelerate Market Expansion, and Ensure Customer Success
ANDERNACH, Germany and MONTREAL, June 25, 2025 /CNW/ -- LTS LOHMANN Therapie-Systeme AG (LTS), a leading pharmaceutical technology company, and Nualtis (formerly IntelGenx Corp.), an innovator in oral thin film (OTF) drug delivery technology, today announced a strategic collaboration to provide customers with robust, reliable, high-quality and cost-competitive large-scale manufacturing capacities. The collaboration leverages LTS's global expertise in technology transfer, scale-up, and manufacturing, providing Nualtis with resources to scale their innovative OTF products and deliver them to patients worldwide. Through this collaboration, the companies will jointly work towards delivering advanced OTF therapies that improve patient outcomes and address pressing healthcare challenges. Nualtis has consistently demonstrated success in advancing OTF technologies. As Nualtis expands its pipeline of OTF programs, the collaboration supports scalable growth while offering its partners greater supply chain flexibility and security. The collaboration provides a unique opportunity for Nualtis to strengthen its position as a leader in the OTF market. As global leader in the development and manufacturing of OTF LTS continues to strengthen its position as a platform specialist by leveraging deep expertise to deliver exceptional outcomes for partners and their patients. Committed to innovation and long-term growth, LTS is actively investing in the future through collaboration with other organizations, advanced R&D resources, and expanded manufacturing capacity. These efforts ensure LTS remains at the forefront of oral thin film technology, driving progress across the healthcare landscape. "Teaming up Nualtis' excellent OTF Formulation platform with LTS's world-class manufacturing capabilities, allows the two companies to accelerate our shared vision of bringing patient-centric therapeutical solutions to our pharma partners." said Bas van Buijtenen, CEO of LTS. "It provides LTS with an exciting opportunity to extend the reach of our mission of "We CARE, We CREATE, We DELIVER" to a wider range of molecules and therapies." "Nualtis is entering a new phase of growth, and this collaboration ensures we are ready," said Dr. Michael Raven, CEO of Nualtis. "Working with LTS allows us to complement our in-house manufacturing capabilities - giving our partners the confidence that we can support them from early development through to full-scale commercialization." Together, Nualtis and LTS will jointly support customers through every phase of drug development and commercialization by combining innovation with proven execution. The companies remain aligned in their commitment to delivering high-quality, reliable, and scalable OTF solutions that improve treatment outcomes across a broad range of indications. About LTS Lohmann Therapie-Systeme AG We CARE. We CREATE. We DELIVER. The driving philosophy behind LTS. As a trusted technology partner for the pharmaceutical industry, we develop and manufacture innovative drug delivery systems such as Transdermal Patches ("TTS") and Oral Thin Films ("OTF") as well as wearable drug delivery devices ("OBDS"). LTS´ commercial offering encompasses more than 20 marketed products and a diverse pipeline of more than 40 development projects targeting multiple disease indications. LTS's innovation pipeline contains both partner-funded as well as proprietary, LTS-funded projects. LTS maintains its leading position through the continuous refinement of its core TTS and OTF technologies and by advancing emerging drug delivery technologies, including Microneedle Array Patches ("MAP") for the transdermal delivery of small and large molecules, biological actives and vaccines. With its SorrelTM wearable drug delivery platform LTS offers patient friendly solutions for complex drugs delivery at home. Founded in 1984, LTS operates today from four sites: in Andernach, Germany, West Caldwell, NJ, USA, St. Paul, MN, USA and Netanya, Israel. LTS has also a representative office in Shanghai, China. About Nualtis Nualtis is a specialty pharmaceutical company advancing innovative drug delivery technologies with a focus on oral thin film (OTF) pharmaceutical products. Nualtis' superior film technologies, including VersaFilm®, DisinteQ™, VetaFilm® and transdermal VevaDerm™, allow for next generation pharmaceutical products that address unmet medical needs. Nualtis' innovative product pipeline offers significant benefits to patients and physicians for many therapeutic conditions. Building on more than a decade of formulation and manufacturing expertise, Nualtis supports pharmaceutical partners in extending product lifecycles and accelerating development timelines. Headquartered in Montreal, the company offers a fully integrated platform that includes research and development, analytical services, regulatory support, and scalable manufacturing from lab to market. With a patient centered approach and a focus on execution excellence, Nualtis delivers smart solutions that meet real world therapeutic needs. Nualtis is a wholly owned subsidiary of atai Life Sciences. For more information, visit or connect with us on LinkedIn and X. For further information, please contact:
